Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-11-20
pubmed:abstractText
The modulation of the hepatic acute-phase reaction (APR) that occurs during inflammation and liver regeneration is important for allowing normal hepatocellular proliferation and the restoration of homeostasis. Activation of acute-phase protein (APP) gene expression by interleukin-6 (IL-6)-type cytokines is thought to be counteracted by growth factors released during hepatic inflammation and regeneration. The epidermal growth factor receptor (EGFR) ligand amphiregulin (AR) is readily induced by inflammatory signals and plays a nonredundant protective role during liver injury. In this paper, we investigated the role of AR as a modulator of liver APP gene expression.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acute-Phase Proteins, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Oncostatin M, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/Stat3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/alpha 1-Antichymotrypsin, http://linkedlifedata.com/resource/pubmed/chemical/amphiregulin
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1010-20
pubmed:meshHeading
pubmed-meshheading:19815304-Acute-Phase Proteins, pubmed-meshheading:19815304-Acute-Phase Reaction, pubmed-meshheading:19815304-Animals, pubmed-meshheading:19815304-Base Sequence, pubmed-meshheading:19815304-Cell Line, Tumor, pubmed-meshheading:19815304-DNA Primers, pubmed-meshheading:19815304-Gene Expression Regulation, pubmed-meshheading:19815304-Glycoproteins, pubmed-meshheading:19815304-Hepatocytes, pubmed-meshheading:19815304-Humans, pubmed-meshheading:19815304-Inflammation, pubmed-meshheading:19815304-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:19815304-Ligands, pubmed-meshheading:19815304-Lipopolysaccharides, pubmed-meshheading:19815304-Liver, pubmed-meshheading:19815304-Liver Regeneration, pubmed-meshheading:19815304-Male, pubmed-meshheading:19815304-Mice, pubmed-meshheading:19815304-Mice, Knockout, pubmed-meshheading:19815304-Oncostatin M, pubmed-meshheading:19815304-Receptor, Epidermal Growth Factor, pubmed-meshheading:19815304-Recombinant Proteins, pubmed-meshheading:19815304-STAT3 Transcription Factor, pubmed-meshheading:19815304-Signal Transduction, pubmed-meshheading:19815304-alpha 1-Antichymotrypsin
pubmed:year
2009
pubmed:articleTitle
The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.
pubmed:affiliation
Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't